Nu Skin Enterprises (NUS) has released an update.
Nu Skin Enterprises, Inc. is set to experience a leadership shift as Joseph Chang steps down as Chief Scientific Officer on March 30, 2024, moving on to lead the company’s Scientific Advisory Board. This change comes as the Board of Directors decides that the Chief Scientific Officer will no longer be part of the executive team. The company acknowledges Dr. Chang’s significant contributions over his 20-year tenure and anticipates his ongoing guidance in his new role.
For further insights into NUS stock, check out TipRanks’ Stock Analysis page.
